Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

PRIMARY IGAN

Clinical trials for PRIMARY IGAN explained in plain language.

Never miss a new study

Get alerted when new PRIMARY IGAN trials appear

Sign up with your email to follow new studies for PRIMARY IGAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1
Sort by
  • New hope for kids with rare kidney disease: drug trial targets protein leak

    Disease control Not yet recruiting

    This study tests a drug called atrasentan in 28 children aged 2 to 18 with IgA nephropathy, a kidney disease that can lead to kidney failure. The main goal is to see if the drug reduces protein in the urine, a sign of kidney damage, over 36 weeks. Participants will take the drug …

    Matched conditions: PRIMARY IGAN

    Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

    Last updated May 01, 2026 20:12 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space